Holen Sie sich die Stockscreener-App
247.10
17.39%
-52.02
Handel nachbörslich:
248.99
1.89
+0.76%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CI?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$299.12
Offen:
$265
24-Stunden-Volumen:
9.33M
Relative Volume:
5.35
Marktkapitalisierung:
$65.96B
Einnahmen:
$261.22B
Nettoeinkommen (Verlust:
$5.40B
KGV:
13.49
EPS:
18.3126
Netto-Cashflow:
$3.94B
1W Leistung:
-19.00%
1M Leistung:
-13.79%
6M Leistung:
-26.72%
1J Leistung:
-21.03%
1-Tages-Spanne:
$245.61
$273.32
1-Wochen-Bereich:
$245.61
$311.34
52-Wochen-Spanne:
$245.61
$350.00
Cigna Group Stock (CI) Company Profile
Firmenname
Cigna Group
Sektor
Branche
Telefon
(860) 226-6000
Adresse
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Vergleichen Sie CI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
247.10 | 79.84B | 261.22B | 5.40B | 3.94B | 18.31 |
|
UNH
Unitedhealth Group Inc
|
344.75 | 321.81B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
76.69 | 102.23B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
ELV
Elevance Health Inc
|
321.95 | 74.75B | 194.82B | 5.53B | 3.77B | 24.45 |
|
HUM
Humana Inc
|
285.61 | 35.20B | 123.11B | 1.58B | 2.44B | 13.03 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-02-06 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-02-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-01-04 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-06-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-04-05 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-22 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-05-27 | Fortgesetzt | Bernstein | Mkt Perform |
| 2022-05-26 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-05-16 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-05-09 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-02-07 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-17 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-06 | Bestätigt | BofA Securities | Buy |
| 2021-08-06 | Bestätigt | Citigroup | Buy |
| 2021-08-06 | Bestätigt | Deutsche Bank | Buy |
| 2021-08-06 | Bestätigt | Jefferies | Buy |
| 2021-08-06 | Bestätigt | Mizuho | Buy |
| 2021-08-06 | Bestätigt | Oppenheimer | Outperform |
| 2021-08-06 | Bestätigt | Truist | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-08-06 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | Eingeleitet | UBS | Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-24 | Eingeleitet | Edward Jones | Buy |
| 2018-03-13 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Overweight |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-11-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-12 | Eingeleitet | Credit Suisse | Outperform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
Alle ansehen
Cigna Group Aktie (CI) Neueste Nachrichten
Cigna Group Reports Strong Q3 2025 Results - TipRanks
Decoding The Cigna Group (CI): A Strategic SWOT Insight - GuruFocus
Cigna (CI) Profit Margin Rise Confirms Bull Case Despite Balance Sheet Concerns - simplywall.st
Cigna Group Stock Hits Day Low Amid Price Pressure, Drops to $298.68 - Markets Mojo
Cigna (CI) Faces Margin Pressure Despite Strong Q3 Earnings - GuruFocus
Cigna Group stock underperforms Thursday when compared to competitors - MarketWatch
Cigna forecasts margin pressures on PBM business - Fierce Healthcare
The Cigna Group (CI) Q3 2025 Earnings Call Highlights: Strong Re - GuruFocus
Cigna falls despite earnings beats on pharmacy benefit margin concerns (CI:NYSE) - Seeking Alpha
Why Cigna (CI) Stock Is Falling Today - Yahoo Finance
Why Is Cigna Stock Plunging Today?Cigna Group (NYSE:CI) - Benzinga
Cigna defends decision to end drug rebates amid record Q3 revenues - InsuranceNewsNet
Cigna's Profit Growth Prospects Look Lighter Than Expected in 2026-27 - Morningstar
Cigna Q3 Earnings Beat Estimates on Evernorth Health Unit Strength - TradingView
Cigna (CI) Reports Strong Q3 Earnings and Introduces New Pharmac - GuruFocus
Cigna stock nosedives on news that ending PBM rebates will lower that segment’s profit - statnews.com
Will The Cigna Group (CGN) stock maintain strong growthJuly 2025 Sector Moves & Reliable Breakout Forecasts - newser.com
Cigna Group SEC 10-Q Report - TradingView
Cigna flags margin pressure in pharmacy benefit unit over next two years; shares fall - MSN
The Cigna Group Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Cigna’s 2026 pharmacy profits could be dampened by transition to rebate-free model - Healthcare Dive
Cigna shares plunge as company warns of margin pressure in pharmacy-benefit unit - Invezz
The Cigna Group Enters Oversold Territory - Nasdaq
Cigna records higher profit as Evernorth business grows - Modern Healthcare
Earnings call transcript: Cigna Q3 2025 beats forecasts, stock plunges - Investing.com
Cigna Stock Tumbles on Margin Warning for Pharmacy Benefit Services - Barron's
Cigna (CI) Projects Strong Financial Growth Trajectory - GuruFocus
Cigna Posts Higher Profit, Revenue as Evernorth Business Continues to Grow - The Wall Street Journal
Cigna (CI) Exceeds Q3 Earnings and Revenue Projections - GuruFocus
Cigna posts $1.87 billion in profit, credits Evernorth - Healthcare Finance News
Cigna stock hits 52-week low at 256.66 USD By Investing.com - Investing.com Nigeria
Barclays Maintains Buy Rating and $383 PT on Cigna (CI) - Insider Monkey
Transcript : The Cigna Group, Q3 2025 Earnings Call, Oct 30, 2025 - MarketScreener
Cigna stock hits 52-week low at 256.66 USD - Investing.com
Cigna (CI) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Cigna Plunges on Expected Pressure in Pharmacy Benefit Segment - Bloomberg.com
Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight? - ts2.tech
Cigna beats quarterly profit estimates on health services strength - MSN
Cigna Breaks Revenue Records And Raises The Bar For 2025 - Finimize
Strong Q3 Performance Highlights Cigna's (CI) Strategic Growth - GuruFocus
Cigna (CI) Q3 Earnings and Revenues Top Estimates - Yahoo Finance
The Cigna Group Reports Q3 2025 Earnings: EPS of $6.98 and Reven - GuruFocus
Cigna’s (NYSE:CI) Q3: Beats On Revenue - TradingView
Cigna: Q3 Earnings Snapshot - San Francisco Chronicle
Cigna sinks 10% after warning of margin squeeze in pharmacy benefit unit; Q3 beats - Investing.com Nigeria
Cigna Outpaces Expectations Thanks To Pharmacy Benefits Arm - Finimize
The Cigna Group Reports Strong Third Quarter 2025 Results - TradingView
Cigna Group beats Q3 estimates, reaffirms full-year outlook By Investing.com - Investing.com Canada
Health insurer Cigna beats quarterly profit estimates on health services strength By Reuters - Investing.com
Cigna Group beats Q3 estimates, reaffirms full-year outlook - Investing.com
Earnings Flash (CI) The Cigna Group Posts Q3 Adjusted EPS $7.83 per Share, vs. FactSet Est of $7.64 - MarketScreener
Finanzdaten der Cigna Group-Aktie (CI)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):